换一批
换一批A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.
作者：
主题词
腺癌(Adenocarcinoma);老年人(Aged);老年人, 80以上(Aged, 80 and over);死亡原因(Cause of Death);脱氧胞苷(Deoxycytidine);疾病恶化(Disease Progression);女(雌)性(Female);胃肠道(Gastrointestinal Tract);人类(Humans);男(雄)性(Male);最大耐受剂量(Maximum Tolerated Dose);中年人(Middle Aged);中性粒细胞减少(Neutropenia);危及器官(Organs at Risk);胰腺肿瘤(Pancreatic Neoplasms);辐射增敏药(Radiation-Sensitizing Agents);放射疗法, 调强适形(Radiotherapy, Intensity-Modulated);血小板减少(Thrombocytopenia);时间因素(Time Factors)
DOI
10.1016/j.ijrobp.2012.02.051
PMID
22543215
发布时间
2022-12-07
- 浏览115
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
